1. Vukovic, Vojin, Karan-Djurasevic, Teodora, Antic, Darko, Pavlovic, Sonja, Mihaljevic, Biljana. 2019. Association of SLC28A3 Gene Expression and CYP2B6*6 Allele with the Response to Fludarabine Plus Cyclophosphamide in Chronic Lymphocytic Leukemia Patients. In Pathology oncology research : POR, 26, 743-752. doi:10.1007/s12253-019-00613-4. https://pubmed.ncbi.nlm.nih.gov/30778771/
2. Fonoudi, Hananeh, Jouni, Mariam, Cejas, Romina B, Sapkota, Yadav, Burridge, Paul W. 2024. Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related Genes. In JACC. CardioOncology, 6, 38-50. doi:10.1016/j.jaccao.2023.11.008. https://pubmed.ncbi.nlm.nih.gov/38510289/
3. Lötsch, Jörn, Hofmann, Wolf Peter, Schlecker, Christina, Ultsch, Alfred, Doehring, Alexandra. . Single and combined IL28B, ITPA and SLC28A3 host genetic markers modulating response to anti-hepatitis C therapy. In Pharmacogenomics, 12, 1729-40. doi:10.2217/pgs.11.99. https://pubmed.ncbi.nlm.nih.gov/22118055/
4. Gündüz, Abdullah, Duman, Derya, Başbinar, Yasemin, Küpeli, Serhan, Karpuz, Derya. 2023. The Role of RARG rs2229774, SLC28A3 rs7853758, and UGT1A6*4 rs17863783 Single-nucleotide Polymorphisms in the Doxorubicin-induced Cardiotoxicity in Solid Childhood Tumors. In Journal of pediatric hematology/oncology, 46, e65-e70. doi:10.1097/MPH.0000000000002768. https://pubmed.ncbi.nlm.nih.gov/37828659/
智鼠故事 
